I have to thank Mr. Fletcher for all his efforts in the past. He really has made a difference. I actually say that about both sides of the bench--we dealt with Carolyn Bennett as well.
To answer your question more specifically, when we called the round table conference in Montreal this past March we specifically reached out to the JODR chairmen, because one of the chairs on the access side was the chair of the clinical practice guidelines of CPAC. So we thought we would take the initiative, take the bull by the horns, and try to see if we could actually create some sort of discussion between the individuals, more so than the bodies per se.
When I talked to you before about it being off to a bad start because the patients should have been involved in the initial setting up of the program, I think that would have made a difference. Nobody from JODR showed up. Admittedly the process had just started, but there has been very little interaction, as far as I know--certainly with our group and with CPAC. I stand corrected if something has changed, but until March nothing had happened.
So I think what we're missing is this interaction between bodies such as JODR and CDR and CPAC on the one hand, but really the patient groups or advocacy groups, to provide input. CPAC is not an advocacy group; it's more of a resource.